BioCentury This Week
BioCentury
Add to My Podcasts
Episodes
About
Reviews
Promote
Ep. 93 - Omicron's Open Questions, Plus the Business Case for Ultra-rare Diseases
19 minutes
Posted Nov 30, 2021 at 12:00 am.
0:00
19:54
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Previous
Ep. 92 - Biogen’s R&D decision, previewing TIGIT & China Summit highlights
Next
Ep. 94 - Woodcock's To-Do List, Maraganore's Takeaways & the Distillery
← See all 405 episodes of BioCentury This Week